RecruitingNot Applicable

Immersive v/s Non-immersive Virtual Reality in Enhancing Upper Limb Functions Among Individuals With Subacute Stage Hemiplegia

United Arab Emirates30 participantsStarted 2024-03-05

Plain-language summary

The goal of this randomized controlled trial is to compare the effectiveness of immersive virtual reality combined with conventional therapy to the effectiveness of non-immersive virtual reality combined with conventional therapy in enhancing upper limb function in subacute hemiplegic stroke patients.

Who can participate

Age range28 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals aged 28-55 years. * Diagnosed with hemiplegia due to stroke. * ≤ Grade 2 on Modified Ashworth scale. * ≤ Stage 2 on Brunnstrom stages of motor recovery. * Score of ≥ 35/36 on Cognitive assessment scale for stroke patients (CASP) Exclusion Criteria: * Contraindications for VR therapy, such as severe motion sickness or photosensitive epilepsy, impaired spatial awareness. * Pre-existing neurological conditions such as spinal cord injury, Multiple sclerosis and so affecting upper limb function.

What they're measuring

Fugl-Meyer Assessment for upper extremity (FMA-UE)

Timeframe: From enrollment to the end treatment at 6 weeks

Graded Wolf Motor function test - The WMFT

Timeframe: From enrollment to the end treatment at 6 weeks

Trial details

NCT IDNCT06615141

SponsorGulf Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-05

Contact for this trial

Athira George, MPT

+971503723635 2022mpt09@mygmu.ac.ae

View on ClinicalTrials.gov More Hemiplegia and/or Hemiparesis Following Stroke trials